Pharma Breathes Sigh Of Relief Over Brexit Deal
'In Best Interest Of Patients In UK and EU'
The ABPI and EFPIA give a cautious welcome, but are pleased it means "ongoing collaboration in key areas including scientific research and cooperation in areas like medicines safety."
